Rosiglitazone-d4 | MedChemExpress (MCE)
Rosiglitazone-d4 is deuterated labeled Rosiglitazone (HY-17386). Rosiglitazone (BRL 49653) is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM). Rosiglitazone is an TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor. Rosiglitazone can be used in the research of obesity and diabetes, senescence, ovarian cancer[1][2][4][7].
| Trivial name | Rosiglitazone-d4 |
| Catalog Number | HY-17386S1 |
| Alternative Name(s) | BRL 49653-d4 |
| Research Area | Neurological Disease; Metabolic Disease; Inflammation/Immunology; Cancer |
| CAS# | 1132641-21-4 |
| Purity | ≥98.0% |
| SMILES | O=C(N1)SC(CC2=CC=C(OC([2H])([2H])C([2H])([2H])N(C)C3=NC=CC=C3)C=C2)C1=O |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/rosiglitazone-d4.html |